Having identified the palmitoylation motif of APLNR, we made a brief substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web-site together with morphine, can inhibit the development of NCP, together with pain incidence, microglial activation, and inflammatory factor release https://sergiogbshx.losblogos.com/26582052/the-best-side-of-block-pain-receptors-with-proleviate